Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries has informed that the meeting of the Board of Directors of the Company will be held on Friday, January 29, 2021 to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2020. Further, pursuant to the Company’s Code of Conduct for Prevention of Insider Trading, the window closure for trading by Designated Persons, commenced on January 01, 2021, and shall end on January 31, 2021 i.e. after 48 hours of the declaration of financial results of the Company on January 29, 2021.

The above information is a part of company’s filings submitted to BSE.